Found 10 matching trials
A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma PHASE2 This study is a prospective, observational clinical study. In this study, 3...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study PHASE2 This is a domestic exploratory, single-arm clinical study enrolling patient...
Show More Location
The Affiliated Hospital of Putian University
Learn More & Join Trial
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations PHASE2 This is a prospective, single-arm study to investigate the efficacy and saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC PHASE2 To evaluate the efficacy and safety of adebrelimab with or without inductio...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors PHASE1 The aim of this study is to observe and evaluate the tolerability, safety, ...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer PHASE2 This is a prospective, single-arm, multicenter clinical study conducted in ...
Show More Location
Affiliated Hospital of Putian University
Learn More & Join Trial
Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC PHASE2 Esophageal cancer is a malignant tumor with high incidence rate and mortali...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging PHASE2 This study will evaluate whether two positron emission tomography/computed ...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC PHASE2 This is a prospective, multi-cohort, exploratory clinical study designed to...
Show More Location
Tangdu Hospital Affiliated to the Fourth Military Medical University
Learn More & Join Trial
A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of a...
Show More Location
2nd Affiliated Hospital, School of Medicine
Learn More & Join Trial